T2S Group, a Moroccan medical technology business, intends to raise MAD1.1 billion ($118 million) by going public on the Casablanca Stock Exchange. The Moroccan Capital Market Authority has granted the firm permission to list its shares, which would be the bourse’s first offering of 2026, the company stated. The subscription period is from July 13 to July 17, and the share price has been established at MAD223.
The offering consists of MAD750 million from the sale of existing shares and MAD350 million from the issue of new shares. The funds, according to the corporation, will finance its objectives for international and African expansion. According to Asharq Business, T2S, founded in 1992, generated MAD1.7 billion in revenue in 2025 and is forecast to grow by about 21% this year.
This year’s net profit is expected to increase to roughly MAD235 million from MAD211 million last year. After the IPO, UK-based Trone Investment Holdings’ 62% ownership of T2S will drop to 42%. Abderraouf Sordo, the company’s founder, owns over 20% of the business. According to the research, the free float is anticipated to reach 23% after listing. Three listings totaling MAD6 billion were made on the exchange last year.
Also Read:
Alliance Française Khobar celebrates Saudi women entrepreneurs.
Albandari Alyamani On Being An Apt At Marketing Skills
